Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia
Cytology-based cervical screening appears to have had a limited effect on the incidence of adenocarcinoma, however HPV vaccination and HPV-based screening will likely play a role in reducing future burden. Using Australia as an example, we estimated the future burden (2015â2040) of adenocarcinoma in...
Main Authors: | Megan A. Smith, Karen Canfell |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-06-01
|
Series: | Papillomavirus Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405852116300787 |
Similar Items
-
Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia.
by: Michaela T Hall, et al.
Published: (2018-01-01) -
Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program
by: Jie-Bin Lew, MPH, et al.
Published: (2017-02-01) -
Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia.
by: Kate T Simms, et al.
Published: (2017-01-01) -
Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand.
by: Jie-Bin Lew, et al.
Published: (2016-01-01) -
Incremental benefits of male HPV vaccination: accounting for inequality in population uptake.
by: Megan A Smith, et al.
Published: (2014-01-01)